Abstracts | 41 and anxiolytic properties in several studies. However there is limited data showing the beneficial effect of linalool following exposure to chronic stress. The aim of the present study was to investigate the effect of linalool in chronic stress rats on behaviour related depressive disorder and BDNF protein in hippocampus. Male Wistar rats were randomly divided into 5 groups, 1) Tween 80 + home cage (HC) 2) Tween 80 + restrain stress (RS) 3) linalool 50 mg/kg + RS 4) linalool 160 mg/kg + RS and 5) linalool 500 mg/kg + RS. Either Tween 80 or linalool was intraperitoneally injected to rats daily for two weeks. Some rats were housed in home cage but the others induced chronic restrained stress (15 min daily) for two weeks. At the end of the treatment, rats were assessed for depressive-like behavior using the forced swimming test. Then, the rats were immediately decapitated and hippocampus was removed for the measurement of BDNF protein by ELISA. Restrained rats injected with linalool 500 mg/kg for two weeks significantly reduced immobility time (p<0.05) but increased climbing time (p<0.05) compared their controls, suggesting that this dose produced antidepressant activity. Linalool had no effect on the level of BDNF protein in hippocampus. Therefore, these findings suggest that linalool decreases behaviour related depressive disorder but has no effect on hippocampal BDNF in chronic restrained stress.
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PS121
Evaluation of extrapyramidal side effects in the treatment of behavioral and psychological symptoms of dementia (BPSD): Interactions between antiAlzheimer drugs and antidepressants Saki Shimizu, Akiyoshi Inada, Yukihiro Ohno, Shunsaku Sogabe, Megumi Yamanaka, Ryoto Yanagisako Osaka University of Pharmaceutical Sciences, Japan Abstract Background/Objectives: Antidepressants are often used in conjunction with anti-Alzheimer drugs to treat the behavioral and psychological symptoms of dementia (BPSD). Here, we studied the interactions between anti-Alzheimer drugs, cholinesterase inhibitors (ChEIs), and antidepressants in inducing extrapyramidal side effects (EPS). Methods: Male ddY mice were used. Using the pole test, we examined the actions of serotonin reuptake inhibitors (SSRIs), fluoxetine and paroxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, a noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine in modulating the ChEIs (galantamine and donepezil)-induced bradykinesia. Results: Both fluoxetine and paroxetine significantly potentiated galantamine-induced bradykinesia in a synergistic manner. The EPS augmentation by fluoxetine was antagonized by ketanserin (5-HT 2 antagonist) and SB-258585 (5-HT 6 antagonist), but not by ondansetron (5-HT 3 antagonist). In contrast to SSRIs, milnacipran and mirtazapine failed to augment galantamineinduced EPS. In addition, combined treatment of prazosin (α 1 antagonist), but not yohimbine (α 2 antagonist), with milnacipran significantly potentiated galantamine-induced EPS.
Conclusion:
The present results indicate that SSRIs and ChEIs synergistically facilitate the EPS induction, via the activation of 5-HT 2 and 5-HT 6 receptors, in the treatment of BPSD. The combination of ChEIs with SNRIs (or NaSSA) is recommended in terms of EPS liability for the BPSD therapy, where the activation of α 1 receptors by SNRIs seems to reduce EPS.
PS122
Overexpression of N-acetyltransferase Shati/Nat8l in the dorsal striatum induces depression-like behaviors in mice. Abstract Depression is one of the most serious psychological disorders, but its pathogenesis remains unclear and the current medical treatment is mainly restrictive effect. We have identified Shati/ Nat8l, which is containing a well-conserved N-acetyltransferase sequence, in the brain of psychosis animal model. Shati/ Nat8l synthesizes N-acetylaspartate (NAA) from L-aspartate and acetyl-CoA, and NAA is subsequently converted into N-acetylaspartylglutamate (NAAG) by being condensed with glutamate. It is reported that NAA and NAAG abundantly exist in human brains and those both or one quantity change in the postmortem brain of patients with psychological disorders including depression. In the present study, to clarify the functional roles of Shati/Nat8l in depression, we investigated various behavioral analyses in Shati/Nat8l-overexpressed mice.
Firstly, the expression levels of Shati/Nat8l mRNA were assessed in the brain of depressed C57BL6J mouse model, which was exposed repeated social defeat stress for 10 days following procedure as physical stress for 10 min and sensory stress for 24 hrs by aggressor ICR mice. And, Shati/Nat8l mRNA in the dorsal striatum of the depression mice significantly increased compared with that of control mice. Therefore, mice were microinjected Shati/Nat8l-inserted or non-inserted (Mock) adeno-associated virus vectors into the dorsal striatum. The Shati/Nat8l-overexpressed mice exhibited decreased social interaction and sucrose preference after subthreshold social defeat stress as the exposure to aggressor ICR mice for 5 min×3 on only one day,which showed normal behaviors in the Mock mice. These two phenotypical impairments in the Shati/Nat8l-overexpressed mice were ameliorated by treatment with a selective serotonin reuptake inhibitor fluvoxamine at the dose of 10 mg/kg i.p., which has no effect in the Mock mice.
These findings suggest that Shati/Nat8l in the striatum play an important role in depression-like behaviors including diminished sociability and pleasure by regulating the serotonergic neuronal system.
PS123
Altered peptide ligands of myelin basic protein produce persistent antidepressant-like effects Abstract Specific objective of the study: This study is aimed to investigate desipramine, venlafaxine and bupropion on depression and anxiety in mice. Methods used: We used a classic tricyclic antidepressant, desipramine; a serotonin-norepinephrine reuptake inhibitör, venlafaxine; a second-generation antidepressant agent that blocks centrally the reuptake of noradrenaline and dopamine, bupropion in forced swimming test (FST), elevated plus maze test (EPM) and open field test. Summary of results: Imipramine (30 mg/kg), desipramine (7.5 mg/kg and 15 mg/kg), venlafaxine (4 mg/kg and 8 mg/kg), bupropion (20 mg/kg and 40 mg/kg) significantly reduced immobility time dose dependently, compared to vehicle-treated group. And also bupropion (40 mg/kg) exerted significant antidepressant-like effects in the mice FST which was more effective than imipramine. Diazepam (2 mg/kg), desipramine (7.5 mg/kg and 15 mg/kg), venlafaxine (4 mg/kg and 8 mg/kg), bupropion (20 mg/kg and 40 mg/ kg) significantly increased the time spent in the open arms dose dependently, compared to the vehicle-treated group. Diazepam (2 mg/kg), desipramine (7.5 mg/kg and 15 mg/kg), venlafaxine 8 mg/kg) and bupropion (20 mg/kg and 40 mg/kg) significantly increased the number of entries into the open arms, compared to the vehicle-treated group. And also bupropion (40 mg/kg) exerted significant anxiolytic-like effects in the mice EPM test which was more effective than diazepam. None of the drugs modified the total distance moved in the open field test. Conclusions reached: desipramine, venlafaxine and bupropion (20 mg/kg) exerted significant antidepressant-like effects which was as effective as imipramine. And also bupropion (40 mg/kg) exerted significant antidepressant-like effects which was more effective than imipramine. Again, desipramine, venlafaxine and bupropion (20 mg/kg) exerted significant anxiolytic-like effects which was as effective as diazepam. And also bupropion (40 mg/ kg) exerted significant anxiolytic-like effects which was more effective than diazepam.
